drugset / Trial / NCT01963728

Comparison of Insulin Therapy in Treating Post-Transplant Diabetes

NCT01963728

Phase 4 Terminated 2 enrolled Inova Health Care Services
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine if the use of insulin isophane results in improved control of blood sugars compared to the use of insulin glargine in new onset diabetes after kidney, lung, or heart transplantation (NODAT).

Timeline

Start
2013-11-27
Primary completion
2015-04-09
Completion
2015-04-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator insulin glargine Protein / enzyme biologic
Comparator insulin isophane Unknown

Indications